Intravenous immunoglobulin for corticosteroid-resistant intestinal Henoch-Schönlein purpura: worth a controlled trial against corticosteroids?

Francesco MorottiGiulia BraccioliniRoberta CaorsiLorella CattaneoMarco GattornoAngelo RavelliEnrico Felici

Published in: Rheumatology (Oxford, England) (2021)

Our observation confirms that IVIG may be useful in the treatment of CS-resistant HScP-related GI vasculitis in children, and highlights the need for more structured research, including a randomized trial against CSs, in order to ascertain their real effectiveness.

Keyphrases

randomized controlled trial
systematic review
young adults
high dose
study protocol
open label
double blind
clinical trial
combination therapy
low dose
drug induced